Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial

Osteoarthritis and Cartilage

Volumn 13, Issue 3, 2005, Pages 206-210

  Detrembleur, Christine ^a   De Nayer, J ^a,b   van den Hecke, A ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Celecoxib; Gait; Knee osteoarthritis; Locomotor mechanism

Indexed keywords

CELECOXIB; PLACEBO; ROFECOXIB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROMYOGRAPHY; FEMALE; GAIT; GONIOMETRY; HUMAN; JOINT MOBILITY; KNEE OSTEOARTHRITIS; KNEE PAIN; LOCOMOTION; MALE; NONPARAMETRIC TEST; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL ANALOG SCALE; WALKING;

AGED; ANTHROPOMETRY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; GAIT; HUMANS; KNEE JOINT; LOCOMOTION; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PROSPECTIVE STUDIES; PYRAZOLES; RANGE OF MOTION, ARTICULAR; SULFONAMIDES; TREATMENT OUTCOME;

EID: 14044279350     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2004.11.002     Document Type: Article

References (17)

1. G.P. Geba A.L. Weaver A.B. Polis M.E. Dixon T.J. Schnitzer Efficacy of rofecoxib, celecoxib, and acetamorphin in osteoarthritis of the knee JAMA 287 2002 64-71
2. M.L. Chavez C.J. DeKorte Valdecoxib: A review Clin Ther 25 2003 817-851
3. M.M. Goldenberg Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis Clin Ther 21 1999 1497-1513
4. D.J. Walker P.S. Heslop L.J. Kay C. Chandler Spontaneous ambulatory activity as a quantifiable outcome measure for osteoarthritis of the knee Br J Rheumatol 37 1998 969-971
5. O. Mejjad S. Favre F. Dujardin J.M. Thominet X. Le Loët J. Weber Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: A randomized, crossover, double-blind study versus placebo Osteoarthritis Cartilage 8 2000 230-235
6. W.G. Bensen J.J. Fiechtner J.I. McMillen W.W. Zhao S.S. Yu E.M. Woods et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial Mayo Clin Proc 74 1999 1095-1105
7. J.N. Insall L.D. Dorr R.D. Scott W.N. Scott Rationale of the Knee Society clinical rating system Clin Orthop 248 1989 13-14
8. R. Davis S. Õunpuu D. Tyburski J. Gage A gait analysis data collection and reduction technique Hum Mov Sci 10 1991 575-587
9. M.G. Benedetti F. Catani A. Leardini E. Pignotti S. Giannini Data management in gait analysis for clinical applications Clin Biomech 13 1998 204-215
10. G.A. Cavagna Force platforms as ergometers J Appl Physiol 39 1975 174-179
11. P.A. Willems G.A. Cavagna N.C. Heglund External, internal, and total work in human locomotion J Exp Biol 198 1995 379-393
12. L. Tesio D. Lanzi C. Detrembleur The 3-D motion of the centre of gravity of the human body during level walking. II. Lower limb amputees Clin Biomech 13 1998 83-90
13. M. Hills P. Armitage The two-period cross-over trial Brit J Clin Pharmacol 8 1979 7-20
14. G.A. Cavagna H. Thys A. Zamboni The sources of external work in level walking and running J Physiol 262 1976 639-657
15. C. Detrembleur A. van den Hecke F. Dierick Motion of the body centre of gravity as a summary indicator of the mechanics of human pathological gait Gait Posture 12 2000 243-250
16. G.A. Cavagna P. Franzetti The determinants of the step frequency in walking in humans J Physiol 373 1986 235-242
17. G.A. Cavagna H. Thys A. Zamboni The sources of external work in level walking and running J Physiol 262 1976 636-657